AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Imugene Limited
Video analysis: IMU.AX
All videosNo video analysis for this stock yet. Request one from our team.
News: IMU.AX
Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating
Figma (NYSE:FIG) was reinstated with a ‘Buy’ rating and a $30 price objective by Bank of America, with the firm arguing that artificial intelligence is...
Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is raising about A$11.12 million before costs through a two-tranche placement, strengthening its balance sheet as...
Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE
Shell PLC (LSE:SHEL, NYSE:SHEL) shares jumped over 2% after it said stronger trading and improved refining margins should support second-quarter...
Imugene reports second BTKi cohort response - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week reported a second complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or BTKi, cohort...
Imugene CEO details azer-cel trial milestone - ICYMI
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or...
Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story
The most striking thing about the standoff that ended on Tuesday is not that it ended, but that it happened at all: a US government blocking a US company...
Imugene reports second complete response in azer-cel BTKi cohort
Just a day after reporting the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel...
Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank
Federal Reserve communications are likely to become shorter, less reliant on forward guidance and more focused on longer-term economic narratives under new...
Similar companies
-
Alterity Therapeutics Limited
ATH.AX
·
Australian Securities Exchange
Compare
-
Arovella Therapeutics Limited
ALA.AX
·
Australian Securities Exchange
Compare
-
Starpharma Holdings Limited
SPL.AX
·
Australian Securities Exchange
Compare
-
Recce Pharmaceuticals Ltd
RCE.AX
·
Australian Securities Exchange
Compare
-
EZZ Life Science Holdings Limited
EZZ.AX
·
Australian Securities Exchange
Compare
-
Radiopharm Theranostics Limited
RAD.AX
·
Australian Securities Exchange
Compare